Amyloid β peptide as a vaccine for Alzheimer's disease involves receptor-mediated transport at the blood–brain barrier
- 1 October 2001
- journal article
- Published by Wolters Kluwer Health in NeuroReport
- Vol. 12 (15), 3197-3200
- https://doi.org/10.1097/00001756-200110290-00011
Abstract
Much research is now focused on a potential vaccine for Alzheimer's disease (AD). Current studies involve administering the amyloid beta peptide (Abeta) in Freund's complete adjuvant, which cannot be used in humans. Our studies show that the immune complex of Abeta is taken up by a receptor-mediated process at the blood-brain barrier (BBB). The success of immunization for AD, therefore, may be critically dependent on circulating Abeta levels which are lower in AD patients compared to AD transgenic mice. Moreover, we have found that modifying the antibody with polyamine increases its BBB permeability and may provide a better approach to passive immunization for Alzheimer's disease.Keywords
This publication has 18 references indexed in Scilit:
- Aβ peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's diseaseNature, 2000
- Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's diseaseNature, 2000
- Unusual spectral energy distribution of a galaxy previously reported to be at redshift 6.68Nature, 2000
- Nasal administration of amyloid-? peptide decreases cerebral amyloid burden in a mouse model of Alzheimer's diseaseAnnals of Neurology, 2000
- Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer diseaseNature Medicine, 2000
- Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouseNature, 1999
- Peripheral injections of Freund's adjuvant in mice provoke leakage of serum proteins through the blood–brain barrier without inducing reactive gliosisBrain Research, 1999
- Receptor-Mediated Transport of Human Amyloid β-Protein 1–40 and 1–42 at the Blood–Brain BarrierNeurobiology of Disease, 1999
- Permeability and Residual Plasma Volume of Human, Dutch Variant, and Rat Amyloid β-Protein 1-40 at the Blood–Brain BarrierNeurobiology of Disease, 1997
- Macromolecular permeability across the blood-nerve and blood-brain barriers.Proceedings of the National Academy of Sciences, 1994